These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 29027687

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS, Matzke GR, Frye RF, Palevsky PM.
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [Abstract] [Full Text] [Related]

  • 3. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.
    Lorenzin A, Garzotto F, Alghisi A, Neri M, Galeano D, Aresu S, Pani A, Vidal E, Ricci Z, Murer L, Goldstein SL, Ronco C.
    Pediatr Nephrol; 2016 Oct; 31(10):1659-65. PubMed ID: 27139897
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
    Isla A, Gascón AR, Maynar J, Arzuaga A, Corral E, Martín A, Solinís MA, Muñoz JL.
    Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
    [Abstract] [Full Text] [Related]

  • 5. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A, Gascón AR, Maynar J, Arzuaga A, Toral D, Pedraz JL.
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.
    Vossen MG, Knafl D, Haidinger M, Lemmerer R, Unger M, Pferschy S, Lamm W, Maier-Salamon A, Jäger W, Thalhammer F.
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584142
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients.
    Levraut J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D.
    Crit Care Med; 1997 Jan; 25(1):58-62. PubMed ID: 8989177
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effectiveness of High Cut-Off Hemofilters in the Removal of Selected Cytokines in Patients During Septic Shock Accompanied by Acute Kidney Injury-Preliminary Study.
    Kade G, Lubas A, Rzeszotarska A, Korsak J, Niemczyk S.
    Med Sci Monit; 2016 Nov 13; 22():4338-4344. PubMed ID: 27840404
    [Abstract] [Full Text] [Related]

  • 13. [Echinocandins: searching for differences. The example of their use in patients requiring continuous renal replacement therapy].
    de la Llama-Celis N, Huarte-Lacunza R, Gómez-Baraza C, Cañamares-Orbis I, Sebastián-Aldeanueva M, Arrieta-Navarro R.
    Rev Esp Quimioter; 2012 Dec 13; 25(4):240-4. PubMed ID: 23303253
    [Abstract] [Full Text] [Related]

  • 14. A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter.
    Reeves JH, Butt WW.
    ASAIO J; 1995 Dec 13; 41(1):100-4. PubMed ID: 7727810
    [Abstract] [Full Text] [Related]

  • 15. Intermittent high-flux albumin dialysis with continuous venovenous hemodialysis for acute-on-chronic liver failure and acute kidney injury.
    Niewinski G, Raszeja-Wyszomirska J, Hrenczuk M, Rozga A, Malkowski P, Rozga J.
    Artif Organs; 2020 Jan 13; 44(1):91-99. PubMed ID: 31267563
    [Abstract] [Full Text] [Related]

  • 16. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
    Lee SC, Lee CW, Shih HJ, Huang SH, Chiou MJ, See LC.
    J Microbiol Immunol Infect; 2014 Jun 13; 47(3):245-53. PubMed ID: 24246191
    [Abstract] [Full Text] [Related]

  • 17. Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients.
    Stapel SN, de Boer RJ, Thoral PJ, Vervloet MG, Girbes ARJ, Oudemans-van Straaten HM.
    Blood Purif; 2019 Jun 13; 48(4):321-329. PubMed ID: 31291614
    [Abstract] [Full Text] [Related]

  • 18. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D, Ji D, Xie H, Xu B, Liu Y, Li L.
    Zhonghua Nei Ke Za Zhi; 2001 Mar 13; 40(3):183-6. PubMed ID: 11798577
    [Abstract] [Full Text] [Related]

  • 19. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM, Freitas LA, Alves VC, Garção MF, Rosa MA, Marques AA.
    Am J Nephrol; 2001 Mar 13; 21(4):264-73. PubMed ID: 11509797
    [Abstract] [Full Text] [Related]

  • 20. Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy.
    Lewis SJ, Switaj LA, Mueller BA.
    Blood Purif; 2015 Mar 13; 40(1):66-71. PubMed ID: 26138225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.